Zdrowie i gospodarka · 30/04/1999

FDA Revokes Interim Policy on Inactive Ingredients in Generic Drugs

The US Food and Drug Administration (FDA) is withdrawing its Interim Inactive Ingredient Policy, which governed generic drug products, due to outdated agency policy, and will instead rely on its current policy framework.